Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
Jakob Wirbel, Paul Theodor Pyl, Ece Kartal, et al.
Nature Medicine (2019) Vol. 25, Iss. 4, pp. 679-689
Open Access | Times Cited: 970

Showing 51-75 of 970 citing articles:

Identification of microbial markers across populations in early detection of colorectal cancer
Yuanqi Wu, Na Jiao, Ruixin Zhu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 163
Gut Bacteriophage: Current Understanding and Challenges
Thomas Sutton, Colin Hill
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 160
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer
Hanyu Chen, Xiaobin Zheng, Xiaoyu Zong, et al.
Gut (2020) Vol. 70, Iss. 6, pp. 1147-1154
Open Access | Times Cited: 159
Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine
Almut Heinken, Johannes Hertel, Geeta Acharya, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 9, pp. 1320-1331
Open Access | Times Cited: 159
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
Shintaro Okumura, Yusuke Konishi, Megumi Narukawa, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 156
Bacteria in cancer initiation, promotion and progression
Geniver El Tekle, Wendy S. Garrett
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 600-618
Closed Access | Times Cited: 154
A Framework for Effective Application of Machine Learning to Microbiome-Based Classification Problems
Begüm D. Topçuoğlu, Nicholas A. Lesniak, Mack T. Ruffin, et al.
mBio (2020) Vol. 11, Iss. 3
Open Access | Times Cited: 153
Rethinking healthy eating in light of the gut microbiome
Anissa M. Armet, Edward C. Deehan, A. O'Sullivan, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 6, pp. 764-785
Open Access | Times Cited: 146
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 145
Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
Yiyun Cao, Joonseok Oh, Mengzhao Xue, et al.
Science (2022) Vol. 378, Iss. 6618
Open Access | Times Cited: 141
Radiotherapy and the gut microbiome: facts and fiction
Jing Liu, Chao Liu, Jinbo Yue
Radiation Oncology (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 135
Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer
Muhammad Afiq Osman, Hui‐min Neoh, Nurul‐Syakima Ab Mutalib, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 127
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors
Ana Montalban‐Arques, Egle Katkeviciutė, Philipp Busenhart, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 10, pp. 1573-1588.e7
Open Access | Times Cited: 120
Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study
Naoyoshi Nagata, Suguru Nishijima, Yasushi Kojima, et al.
Gastroenterology (2022) Vol. 163, Iss. 1, pp. 222-238
Open Access | Times Cited: 119
Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells
Amina Iftekhar, Hilmar Berger, Nassim Bouznad, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 117
A comprehensive framework for early-onset colorectal cancer research
Cathy Eng, Alexandre A. Jácome, Rajiv Agarwal, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 3, pp. e116-e128
Closed Access | Times Cited: 112
Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly
Nicolai Karcher, Eleonora Nigro, Michal Punčochář, et al.
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 111
Multi-level analysis of the gut–brain axis shows autism spectrum disorder-associated molecular and microbial profiles
James T. Morton, Dong-Min Jin, Robert H. Mills, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 7, pp. 1208-1217
Open Access | Times Cited: 106
Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome
Wen‐Bing Jin, Tingting Li, Da Huo, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 547-562.e22
Open Access | Times Cited: 104
Microbiome-based interventions to modulate gut ecology and the immune system
Thomas C. A. Hitch, Lindsay J. Hall, Sarah Kate Walsh, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1095-1113
Open Access | Times Cited: 102
Roseburia intestinalisgenerated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+T cells
Xing Kang, Changan Liu, Yanqiang Ding, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2112-2122
Open Access | Times Cited: 96
Population structure discovery in meta-analyzed microbial communities and inflammatory bowel disease using MMUPHin
Siyuan Ma, Dmitry Shungin, Himel Mallick, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 88
A deep siamese neural network improves metagenome-assembled genomes in microbiome datasets across different environments
Shaojun Pan, Chengkai Zhu, Xing‐Ming Zhao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota
Kaitlyn D. LaCourse, Martha A. Zepeda‐Rivera, Andrew G. Kempchinsky, et al.
Cell Reports (2022) Vol. 41, Iss. 7, pp. 111625-111625
Open Access | Times Cited: 87
Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota—Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics
Divakar Dahiya, Poonam Singh Nee Nigam
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3074-3074
Open Access | Times Cited: 87

Scroll to top